APA (7th ed.) Citation

Tang, P., Bao, S., Xie, W., Xiao, Z., Wu, X., & Ge, H. Development and application of a UHPLC-MS/MS method for the simultaneous determination of firmonertinib and its main metabolite AST-5902 in rat plasma: A study on the in vivo drug interaction between firmonertinib and paxlovid. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Tang, Peng-Fei, Su-Su Bao, Wei-Fei Xie, Zhong-Xiang Xiao, Xue-Meng Wu, and Hong-Lei Ge. Development and Application of a UHPLC-MS/MS Method for the Simultaneous Determination of Firmonertinib and Its Main Metabolite AST-5902 in Rat Plasma: A Study on the in Vivo Drug Interaction Between Firmonertinib and Paxlovid. Frontiers Media S.A.

MLA (9th ed.) Citation

Tang, Peng-Fei, et al. Development and Application of a UHPLC-MS/MS Method for the Simultaneous Determination of Firmonertinib and Its Main Metabolite AST-5902 in Rat Plasma: A Study on the in Vivo Drug Interaction Between Firmonertinib and Paxlovid. Frontiers Media S.A.